IntelleWave is a non-invasive cardiac monitoring device that provides Quantitative assessment of the Autonomic Nervous System (ANS) on the basis of Heart Rate Variability (HRV) and blood pressure analysis. The system is used to objectively confirm or exclude a Cardiovascular Autonomic Neuropathy (CAN), a Diabetic Autonomic Neuropathy (DAN) and other dysautonomia problems. It is able to recognized Beta-Blockers overdozage and Risk of Sudden Cardiac Arrest. Intellewave also can provide "real-time" up to 24hr quantitative ANS assessment. The list of potential application by this regime is next:
- Monitor ANS status during anesthesia.
- Monitor ANS status in intensive care to see effectiveness of
   medication.
- Monitor ANS status by implantable devices.
- Using for sleep studies to see the difference between "sleep  
   time"  and "awake time".
   download brochure >>>